NFKB1 and myelodysplastic syndrome: Consistent with that finding, mutations in myeloid neoplasms in the splicing factors SF3B1 and SRSF2 enhance NF-κB activity [171] and lead to the activation of NLRP3 acting as a driver for MDS [172].